Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NVCR compared with NPCE: revenue, margins and what each company keeps, and the suppliers and customers both name
NVCR
NovoCure Ltd
Change
Mkt cap
Revenue
Revenue
NPCE
NeuroPace Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
NVCR
NovoCure Ltd
vs
NPCE
NeuroPace Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
NVCR: latest quarter is a loss; flow not drawable. NPCE: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NVCR
3
ZLAB
Zai Lab
customer
—
Zai Lab (Shanghai)
unlisted
customer
—
Zai
unlisted
customer
Shared
0
No shared counterparties.
Only NPCE
4
—
DIXI Medical USA
unlisted
supplier
GBCI
Greatbatch
supplier
—
Micro Systems Technologies Management
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Rapport Therapeutics
unlisted
customer
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NVCR, solid
NPCE, dashed
NVCR
NovoCure Ltd
Change
13.14
▲
+0.23%
· post 13.14
Mkt cap
$1.5B
Revenue
$193M
Q3 FY26
Revenue
$655M
FY25
NPCE
NeuroPace Inc
Change
12.28
▼
−5.61%
· post 12.28
Closed
Oct 30 '26
Mkt cap
$422.2M
Revenue
$23M
Q2 FY26
Revenue
$96M
FY25
vs
Compare
Closed
Oct 30 '26
NVCR
NovoCure Ltd
vs
NPCE
NeuroPace Inc
13.14
▲
+0.23%
post 13.14
Price
12.28
▼
−5.61%
post 12.28
$1.5B
Mkt cap
$422.2M
Q3 FY26
$193M
Revenue
$23M
Q2 FY26
FY25
$655M
Revenue
$96M
FY25
Change
Change
NVCR
13.14
▲
+0.23%
vs
NPCE
12.28
▼
−5.61%
Closed
Oct 30 '26